Vet practice valuation: how EBITDA multiples work

Most owners first hear their practice's value as a single number: "about 12 times EBITDA." That number hides most of what matters. The multiple depends on which kind of practice you are, the EBITDA it's applied to is an adjusted figure rather than the profit on your tax return, and the price you're quoted is not the cash you receive at closing. This guide explains how veterinary practice valuation works in 2026, using the most recent public deal data we could find, so you can read an offer or a broker's estimate with clear eyes.

Vet Rounds has no relationship with any broker, consolidator, appraiser or lender. Nothing here is legal, tax or investment advice.

The basic formula

For most general practices sold to corporate groups, value is set as a multiple of normalized EBITDA:

Enterprise value = normalized EBITDA × multiple

EBITDA stands for earnings before interest, taxes, depreciation and amortization. Broker Ackerman Group describes it as an approximation of the cash a practice generates from day-to-day operations, ignoring how it is financed and large equipment purchases (Ackerman Group, Normalized EBITDA explained). Interest is added back because a buyer expects your debts to be paid off at closing. Income taxes are added back because the buyer has its own tax position. Depreciation and amortization are non-cash charges (same source).

The multiple then tells you how many years of today's cash flow the buyer is paying for. Ackerman's own example: a practice with $500,000 of EBITDA sold at 13x is valued at $6.5 million, or 13 years of current cash flow, and the buyer expects to grow that EBITDA after closing (same source).

Step 1: Normalize the EBITDA

The EBITDA used in a valuation is rarely the number on your profit-and-loss statement. Buyers and advisers "normalize" it to show what the practice would have earned in the last 12 months under a corporate owner. Ackerman lists typical add-backs (expenses removed because a corporate owner would not incur them) as (Ackerman Group):

auto expenses and auto insurance;
large equipment or building purchases that were expensed, such as digital radiography, surgery lights, new floors or cabinets (routine repairs and maintenance contracts are not added back);
travel and meals not directly related to the business;
salaries for family members who will not stay on after the sale;
an adjustment of rent to market rates if you own the building and charge yourself more or less than market.

Normalization can also move EBITDA down. Ackerman says it applies "market" costs for items such as health insurance, continuing-education allowances and staff meals, and notes that each buyer makes its own adjustments (same source). The practical point: two buyers can look at the same books and arrive at different EBITDA figures before they ever discuss a multiple.

An illustrative example (not market data)

Suppose a practice's books show $400,000 of operating profit before interest, taxes, depreciation and amortization. The owner ran $20,000 of vehicle costs through the practice, expensed a $60,000 radiography upgrade, and pays a family member $35,000 who will leave at the sale. Normalized EBITDA might be about $515,000 before any downward market adjustments (calc: 400,000 + 20,000 + 60,000 + 35,000). At an 11.8x multiple, the gap between the two EBITDA figures, $115,000, is worth about $1.36 million of value (calc). That is why the add-back schedule deserves as much attention as the multiple.

Get the business of vet practice in five minutes, every Monday.Free. Unsubscribe any time. We never sell or share your email.

Subscribe free

Step 2: Find the right multiple for your kind of practice

Veterinary deals are private, so public multiple data is thin. The most detailed recent figures we found come from Ackerman Group's own transactions. Treat them as one adviser's data, not the whole market.

Measure (Ackerman Group transactions)	Figure	Source
Weighted-average GP multiple, H1 2026	13.4x EBITDA (12.4x in H2 2025)	Q2 2026 update
Large GPs (5+ DVMs, over $750,000 EBITDA), H1 2026	14.7x	same
All other GPs, H1 2026	11.8x, flat for two-plus years	same
Market range, H1 2026	8x to 16x	same
Hospitals in the H1 2026 sample	20	same
A+ practices with signed letters of intent, Q4 2026	16x+	Q3 2026 Market Pulse (PDF)
A recently closed specialty practice	10x to 11x	same

In its October 2026 report, Ackerman says its Q3 average multiples declined slightly because few deals closed in the quarter and no A+ practices closed in the most recent three months, but that it expects full-year 2026 multiples to end up similar to the first half (Ackerman Group Q3 2026). It also reports that specialty and emergency practices continue to sell at a discount to strong general practices (same source).

The takeaway: if your practice has fewer than five veterinarians, the most relevant published reference point is the "all other GPs" figure, 11.8x, not the 13.4x headline or the 16x+ deals that make the news.

Step 3: What moves your multiple up or down

Ackerman attributes the gap between large and smaller practices to two things: scarcity of large, highly profitable practices for sale, and buyers with strong track records competing for them (Ackerman Group Q2 2026). It describes the practices that saw real multiple expansion as those with scale, strong EBITDA, stable DVM teams and a building that can absorb more growth (same source). Its EBITDA guide adds that faster historical growth in revenue and EBITDA supports a higher multiple (Ackerman Group).

Growth is harder to show right now. Ackerman expects 2026 to be the fifth straight year of 2% to 3% declines in veterinary invoices (Q3 2026), and the Vetsource/AVMA tracker shows visits down 2.0% and revenue up 3.4% over the last 12 months across 6,372 practices (Vetsource Veterinary Analytics, Oct 20, 2026). A practice that holds or grows its visit count in that environment has a real story to tell buyers. Our guide to raising prices without losing clients covers how to protect visits while fees rise, and the 12 KPIs to watch monthly shows which numbers buyers will ask for.

Step 4: Price is not cash at closing

The headline value is usually paid in pieces. In Ackerman's H1 2026 data, cash at closing averaged 8.7x EBITDA, or 65% of total consideration (Q2 2026). In its Q3 report it puts cash at closing at 45% to 80% depending on the transaction, and says that range is very buyer-dependent (Q3 2026).

The rest can come as retained ownership, equity in the buyer's parent company ("TopCo equity"), earnouts or seller notes. Ackerman reports that 68% of the hospitals it sold in the first nine months of 2026 were joint ventures, up from 49% in 2025, and that transactions including TopCo equity are holding just under 70% (same source). Its Q3 report profiles the owner of a four-DVM practice in Boone, Iowa, who turned down the highest headline offer, 14x EBITDA with TopCo equity, hard-to-achieve earnout hurdles and only 8x in cash at closing. She chose an offer with 10x in cash at closing and 13x total value once achievable revenue hurdles are met (same source).

When you compare offers, line them up on cash at closing, then on what the deferred part depends on and when it can be turned into cash. Our guide to selling to a corporate or private buyer walks through each deal component.

Step 5: Know how goodwill is taxed

In most practice sales, a large share of the price is goodwill: the value of the practice above its equipment and other hard assets. For federal tax purposes, goodwill, going-concern value, the client list, workforce in place and covenants not to compete are "section 197 intangibles," which the buyer amortizes over 15 years (26 U.S.C. § 197, via Cornell LII). In an asset sale where goodwill could attach, both seller and buyer must report how the price was allocated among asset classes on IRS Form 8594 (IRS, About Form 8594).

How the price is split between goodwill, equipment, non-compete payments and any personal goodwill changes what you keep after tax. Settle the allocation with your CPA before you sign a letter of intent, not after.

Valuation, appraisal and broker estimates

You may hear three different numbers. A broker's estimate is an opinion of what buyers might pay, built from the deals that broker has seen. Ackerman itself warns owners that brokers with only a few closed deals a year can produce unreliable valuation conclusions, and suggests asking how many similar, closed transactions a broker is relying on (Ackerman Group). A formal appraisal is prepared by a credentialed appraiser and is what lenders, courts and partners typically rely on. A buyer's letter of intent is the only number that reflects what someone will actually pay, and it still depends on diligence.

If you are selling to an associate or another private buyer who will borrow, expect the lender to require its own valuation. Ask the lender early what it needs, because it can cap what the buyer can finance. Our selling guide covers SBA-backed private sales.

A valuation checklist

Pull three years of profit-and-loss statements and the trailing 12 months.
Build an add-back schedule with your CPA, with a document for every item.
Adjust rent to market if you own the real estate.
Identify which multiple bucket your practice falls in: DVM count, EBITDA size, growth and specialty mix.
Track visits, revenue and new clients monthly so you can show the trend.
Ask any adviser how many comparable, closed deals support their number.
Compare offers on cash at closing first, then on the deferred terms.
Settle the purchase-price allocation with your CPA before signing a letter of intent.

FAQ

What is a typical EBITDA multiple for a vet practice in 2026?

In Ackerman Group's first-half 2026 transactions, general practices averaged 13.4x EBITDA, but practices with 5+ DVMs and over $750,000 of EBITDA averaged 14.7x, while all other general practices averaged 11.8x. The range was 8x to 16x. These figures come from one broker's 20 transactions, not the whole market.

What is normalized EBITDA?

It is EBITDA adjusted to show what the practice would have earned under a corporate owner. Typical add-backs include owner auto expenses, expensed equipment or building purchases, non-business travel, pay for family members who will leave, and rent adjusted to market. Buyers may also apply their own market costs for items such as health insurance.

How much of the sale price is paid in cash at closing?

In Ackerman Group's first-half 2026 data, cash at closing averaged 8.7x EBITDA, or 65% of total consideration. Its October 2026 report puts the range at 45% to 80%, depending on the buyer and deal.

Are vet practice valuations going down?

Ackerman Group's Q3 2026 report says its average multiples dipped slightly in the quarter because few deals closed, but it expects full-year 2026 multiples to end up similar to the first half, with two A+ practices under letters of intent at 16x+ EBITDA.

How is goodwill taxed when I sell my practice?

Goodwill is a section 197 intangible, which the buyer amortizes over 15 years. In an asset sale, buyer and seller report the price allocation on IRS Form 8594. How the price is allocated affects your after-tax proceeds, so settle it with your CPA before signing a letter of intent.

Want the numbers that move every week? They’re in the Monday brief.Free. Unsubscribe any time. We never sell or share your email.

Subscribe free

Keep reading

Sources

Sources accessed October 21, 2026 (PT). Figures marked calc are Vet Rounds arithmetic on the linked data.

Disclosure: Researched with AI tools. Written, edited and fact-checked by Matthew C. and our editorial team. Nothing here is clinical, legal or tax advice. Spot an error? Email hello@veterinaryrounds.com and we’ll correct it.

Vet practice valuation: how EBITDA multiples really work.